Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remepy
New York, New York, United Statesremepy.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Remepy has demonstrated effects of its digital molecule interventions in clinical trials using fMRI imaging, blood and saliva samples analysis, and standardized questionnaires. It has shown that its patent-pending digital therapies can modulate blood biomarkers.
- Therapeutic areas
- OncologyOphthalmologyImmunologyNeurology
- Modalities
- Hybrid drugs (combination of traditional drugs with digital molecules)
- Industry
- Digital Health Medical Devices
02
Partnerships
Pharmaceutical companies (specific names not mentioned)
Beyond the preview
Go deeper on Remepy.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Remepy.